Lab-grown ‘mini-stomachs’ could shed light on children’s COVID symptoms

A ‘lab-grown model’ of the human stomach, that can be used to study how infections affect the gastrointestinal system, has been developed for the first time. A UCL-led team of international scientists have built on...

Automated drug discovery platform brings about paradigm change for research

Bringing a single new drug to market takes years of research and costs billions – with the COVID-19 pandemic highlighting even more how critical it is to accelerate this process. The high costs and...

Relentlessly searching for the cure

Martina Slapkova - Research Information Co-ordinator at the Motor Neurone Disease Association Motor neuron disease (MND), also known as Amyotrophic Lateral Sclerosis across the globe, has been puzzling researchers and clinicians ever since it was...

Depression up, Covid-19 down in disease study list

Depression is now one of the top five most studied disease areas in clinical development, according to new global analysis by Phesi. The mid-year analysis of all this year’s trials to date reveals that Covid-19...

IBM releases novel AI-powered technology to accelerate medical research for COVID-19

IBM has today released a new set of cloud- and AI-powered technologies to help researchers, doctors and scientists accelerate COVID-19 drug discovery. These novel resources, from across IBM and available beginning today (Friday 3 April)...

Bacteria can develop strong immunity for protection against viruses

A new study hopes to exploit newly characterised defence systems in bacteria to compare changes to the human genome. University bioscientists have been working on the research to demonstrate the complex workings of bacterial innate...

Pioneering technique paves way for fast and cheap fabrication of rapid medical diagnostic tools

Breakthrough promises to democratise microfluidics and lab-on-a-chip technology, benefiting resource-poor countries and settings. New technology developed by the University of Bristol has the potential to accelerate uptake and development of on-chip diagnostic techniques in parts...

How a Novel Drug Discovery Technology Could Help in the Fight Against COVID-19

By Dr Asif Tulah, Alcyomics Alcyomics has been adapting its service provision and assays to play their part in the race to find new treatments for COVID-19 (SARS-CoV-2) and to better understand how this virus works....

TWO NEW FORMS OF THERAPY GIVE HOPE WHEN BLOOD CANCER RETURNS AND BOWEL CANCER...

Scientists trial new way to boost CAR T-cell therapy Cancer Research UK is collaborating with Aleta Biotherapeutics to trial a new therapy that reboots a treatment for some people whose blood cancer starts to come back. The new...

Diagnostic devices reimagined

Diagnostic devices are coming on in leaps and bounds but you may be surprised to learn that one device that’s remained much the same since the late 1950s is the colonoscope. One researcher working...

Bringing patients and providers together one tweet at a time

As an open forum for human interaction, social media have become the great equalizer of health information – providing a means for patients and health care providers to connect outside of the hospital or...

Clinical trials for gene and cell therapies

In early 2020, the Cell and Gene Therapy Catapult (CGTC) reported that there were 127 ongoing trials in advanced therapy medicinal products (ATMP) in the UK. This represented 12 percent of trials globally, helping...

Adult Vaccination

“Vaccination can provide cost-effective protection against a host of diseases throughout life, but remains an underused public-health strategy in adults for the promotion of healthy ageing. Without specific vaccination programmes for the adult population...

1 in 6 children ‘neurodivergent’ as autism numbers quadruple

The number of children diagnosed with Attention-deficit /hyperactivity disorder (ADHD), autism and other neurodevelopmental disorders classifying them as ‘neurodivergent’, has rocketed in both the UK and US.  “Now, one in six children in the US...

There’s more to collagen than cosmetics…

Big strides are being made in collagen clinical development, particularly in treatment of age-related conditions. Dr Gen Li, president and founder of Phesi, discusses the increase in collagen research, and its clinical and biological...

Protecting the confidentiality of individuals vs. the desire to improve healthcare through data

Wendy Lloyd-Goodwin, Founder of Life Science Law, looks at the implications of a new EU-wide framework for health data, including for research and clinical trials. The EU is hoping to achieve a quantum leap forward...